U.S. Healthcare Spending, courtesy of Peter G. Peterson Foundation
2018 Event Information
Thursday, March 1
8:30 a.m. – 4:00 p.m. ET
Masur Auditorium, Building 10
National Institutes of Health
Sponsored by NCATS and the NIH Clinical Center (CC), the event will feature presentations, posters, exhibits, an art show and CC tours. Admission is free and open to the public. In association with Global Genes®, participants are encouraged to wear their favorite pair of jeans. Be sure to follow the event on social media using #RDDNIH.Website • Agenda • Register • Webcast • Posters/Exhibits
About Rare Disease Day
EURORDIS sponsored the first Rare Disease Day in Europe on Feb. 29, 2008. The United States joined the first global observance the following year along with 23 other countries. Visit Rare Disease Day USA and International Rare Disease Day for more information.
About Rare Disease Day at NIHEach year since 2010, the slogan for NIH’s event has been “Patients & Researchers — Partners for Life.” This slogan aligns with NCATS’ philosophy that researchers must work closely with patients, families, caregivers and advocacy groups to maximize the chances for success in advancing rare diseases research. This philosophy has been put into practice in NCATS’ Rare Diseases Clinical Research Network, Therapeutics for Rare and Neglected Diseases program, and the Genetic and Rare Diseases Information Center, among other efforts.
The goals of Rare Disease Day at NIH are to:
- Demonstrate and reiterate the NIH commitment to rare diseases research to help patients.
- Highlight NIH-supported rare diseases research and the development of diagnostics and treatments.
- Initiate a mutually beneficial dialogue among public and private researchers, patients, patient advocates, and policymakers.
- Exchange the latest rare diseases information with stakeholders to advance research and therapeutic efforts.
- Put a face on rare diseases by sharing stories of patients, their families and their communities.
NCATS and Rare Diseases Research
About 7,000 rare diseases affect humans, of which only a few hundred have any treatment. Although each rare disease affects fewer than 200,000 Americans, in total these illnesses affect an estimated 25 million people in the United States. Less than 5 percent of rare diseases have a treatment.
NCATS is all about getting more treatments to more patients more quickly. The Center tackles rare diseases research through collaborative projects to study the commonalities and underlying molecular causes of these disorders. This approach creates the potential to speed the development of treatments for a number of rare and common diseases at the same time.